Difference between revisions of "Succinate dehydrogenase-deficient renal cell carcinoma"
Jump to navigation
Jump to search
(6 intermediate revisions by the same user not shown) | |||
Line 9: | Line 9: | ||
| LMDDx = [[renal oncocytoma]], [[chromophobe renal cell carcinoma]], [[clear cell renal cell carcinoma]], other [[renal tumours with eosinophilic cytoplasm]] | | LMDDx = [[renal oncocytoma]], [[chromophobe renal cell carcinoma]], [[clear cell renal cell carcinoma]], other [[renal tumours with eosinophilic cytoplasm]] | ||
| Stains = | | Stains = | ||
| IHC = SDHB -ve, CK7 -ve, CD117 -ve, PAX8 +ve | | IHC = SDHB -ve, CK7 -ve, CD117 -ve, PAX8 +ve, CA9 -ve | ||
| EM = | | EM = | ||
| Molecular = | | Molecular = | ||
Line 32: | Line 32: | ||
'''Succinate dehydrogenase-deficient renal cell carcinoma''', also '''[[succinate dehydrogenase]] renal cell carcinoma''' (abbreviated '''SDH-RCC'''), is a very rare type of [[renal cell carcinoma]]. | '''Succinate dehydrogenase-deficient renal cell carcinoma''', also '''[[succinate dehydrogenase]] renal cell carcinoma''' (abbreviated '''SDH-RCC'''), is a very rare type of [[renal cell carcinoma]]. | ||
It is | It is in the 2016 World Health Organization classification of renal neoplasia. | ||
==General== | ==General== | ||
Line 38: | Line 38: | ||
*May be assocated with [[paraganglioma]] and familial, as with several SDH mutations.<ref name=pmid25800244>{{Cite journal | last1 = Hernandez | first1 = KG. | last2 = Ezzat | first2 = S. | last3 = Morel | first3 = CF. | last4 = Swallow | first4 = C. | last5 = Otremba | first5 = M. | last6 = Dickson | first6 = BC. | last7 = Asa | first7 = SL. | last8 = Mete | first8 = O. | title = Familial pheochromocytoma and renal cell carcinoma syndrome: TMEM127 as a novel candidate gene for the association. | journal = Virchows Arch | volume = | issue = | pages = | month = Mar | year = 2015 | doi = 10.1007/s00428-015-1755-2 | PMID = 25800244 }}</ref> | *May be assocated with [[paraganglioma]] and familial, as with several SDH mutations.<ref name=pmid25800244>{{Cite journal | last1 = Hernandez | first1 = KG. | last2 = Ezzat | first2 = S. | last3 = Morel | first3 = CF. | last4 = Swallow | first4 = C. | last5 = Otremba | first5 = M. | last6 = Dickson | first6 = BC. | last7 = Asa | first7 = SL. | last8 = Mete | first8 = O. | title = Familial pheochromocytoma and renal cell carcinoma syndrome: TMEM127 as a novel candidate gene for the association. | journal = Virchows Arch | volume = | issue = | pages = | month = Mar | year = 2015 | doi = 10.1007/s00428-015-1755-2 | PMID = 25800244 }}</ref> | ||
*Primarily described with a ''SDHB mutation''.<ref name=pmid25034258/> | *Primarily described with a ''SDHB mutation''.<ref name=pmid25034258/> | ||
**SDHA has been described.<ref name=pmid25034258 >{{Cite journal | last1 = Williamson | first1 = SR. | last2 = Eble | first2 = JN. | last3 = Amin | first3 = MB. | last4 = Gupta | first4 = NS. | last5 = Smith | first5 = SC. | last6 = Sholl | first6 = LM. | last7 = Montironi | first7 = R. | last8 = Hirsch | first8 = MS. | last9 = Hornick | first9 = JL. | title = Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma. | journal = Mod Pathol | volume = 28 | issue = 1 | pages = 80-94 | month = Jan | year = 2015 | doi = 10.1038/modpathol.2014.86 | PMID = 25034258 }}</ref> | **SDHA has been described.<ref name=pmid25034258>{{Cite journal | last1 = Williamson | first1 = SR. | last2 = Eble | first2 = JN. | last3 = Amin | first3 = MB. | last4 = Gupta | first4 = NS. | last5 = Smith | first5 = SC. | last6 = Sholl | first6 = LM. | last7 = Montironi | first7 = R. | last8 = Hirsch | first8 = MS. | last9 = Hornick | first9 = JL. | title = Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma. | journal = Mod Pathol | volume = 28 | issue = 1 | pages = 80-94 | month = Jan | year = 2015 | doi = 10.1038/modpathol.2014.86 | PMID = 25034258 }}</ref> | ||
**SDHC has been described.<ref name=pmid23083876/> | **SDHC has been described.<ref name=pmid23083876/> | ||
<!-- **SDHD has been described.{{fact}} --> | <!-- **SDHD has been described.{{fact}} --> | ||
Line 103: | Line 103: | ||
==IHC== | ==IHC== | ||
Features: | Features: | ||
*SDHB -ve (11 of 11 cases<ref name=pmid25034258 | *SDHB -ve (11 of 11 cases<ref name=pmid25034258/>). | ||
**Normal tubules +ve. | **Normal tubules +ve. | ||
**May be (pseudo)negative in clear cells (as few mitochondria). | **May be (pseudo)negative in clear cells (as few mitochondria). | ||
*CD117 -ve - '''important'''. | *CD117 -ve - '''important'''. | ||
*CA9 -ve. | |||
Others: | Others: | ||
*PAX8 +ve. | *PAX8 +ve. | ||
*EMA +ve (10/10<ref name=pmid25034258/>). | *EMA +ve (10/10<ref name=pmid25034258/>). | ||
*CK7 -ve (1 +ve/35<name=pmid25025441/>). | *CK7 -ve (1 +ve/35<ref name=pmid25025441/>). | ||
*AE1/AE3 -ve/+ve (4 +ve/10<ref name=pmid25034258/>). | *AE1/AE3 -ve/+ve (4 +ve/10<ref name=pmid25034258/>). | ||
*CK20 -ve. | *CK20 -ve. |
Latest revision as of 19:40, 11 October 2024
Succinate dehydrogenase-deficient renal cell carcinoma | |
---|---|
Diagnosis in short | |
SDH-deficient renal cell carcinoma (left of image). H&E stain. | |
| |
LM | eosinophilic cells with clear (flocculent) cytoplasmic inclusions, round nuclei with mildly granular chromatin pattern, intratumoural mast cells, solid architecture |
LM DDx | renal oncocytoma, chromophobe renal cell carcinoma, clear cell renal cell carcinoma, other renal tumours with eosinophilic cytoplasm |
IHC | SDHB -ve, CK7 -ve, CD117 -ve, PAX8 +ve, CA9 -ve |
Gross | mass lesion, commonly cystic |
Grossing notes | partial nephrectomy grossing, total nephrectomy for tumour grossing |
Site | kidney - see kidney tumours |
| |
Syndromes | familial pheochromocytoma and renal cell carcinoma syndrome |
| |
Prevalence | extremely rare |
Prognosis | usually good prognosis (limited data) |
Clin. DDx | other kidney tumours |
Succinate dehydrogenase-deficient renal cell carcinoma, also succinate dehydrogenase renal cell carcinoma (abbreviated SDH-RCC), is a very rare type of renal cell carcinoma.
It is in the 2016 World Health Organization classification of renal neoplasia.
General
- Extremely rare - estimated to represent up to 0.2% of renal cell carcinomas.[1]
- May be assocated with paraganglioma and familial, as with several SDH mutations.[2]
- Primarily described with a SDHB mutation.[3]
- Usually good prognosis.
Gross
- Mass lesion - commonly cystic.
Microscopic
Features:[3]
- Eosinophilic cells with clear (flocculent) cytoplasmic inclusions. ‡
- Round nuclei with mildly granular chromatin pattern.
- Intratumoural mast cells - usu. not prominent.
- Solid architecture - typical.
Notes:
- ‡ Occasional cells may look like signet ring cells.
- Typically low ISUP nucleolar grade.
- May be sarcomatoid.
DDx:
- Renal oncocytoma - granular cytoplasm.
- Chromophobe renal cell carcinoma.
- Clear cell renal cell carcinoma.
- Other renal tumours with eosinophilic cytoplasm.
Images
www:
- SDHB-RCC - poor quality histology image (nih.gov).[4]
- SDHC-RCC (nih.gov).[4]
- SDH-deficient RCC (nature.com).[3]
Case 1
Case 2
Case 3
Pictures demonstrates the variability between different regions of the tumour:
IHC
Features:
- SDHB -ve (11 of 11 cases[3]).
- Normal tubules +ve.
- May be (pseudo)negative in clear cells (as few mitochondria).
- CD117 -ve - important.
- CA9 -ve.
Others:
- PAX8 +ve.
- EMA +ve (10/10[3]).
- CK7 -ve (1 +ve/35[1]).
- AE1/AE3 -ve/+ve (4 +ve/10[3]).
- CK20 -ve.
- CD10 usually focal (most common) or -ve.[1]
See also
References
- ↑ 1.0 1.1 1.2 Gill, AJ.; Hes, O.; Papathomas, T.; Šedivcová, M.; Tan, PH.; Agaimy, A.; Andresen, PA.; Kedziora, A. et al. (Dec 2014). "Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients.". Am J Surg Pathol 38 (12): 1588-602. doi:10.1097/PAS.0000000000000292. PMID 25025441.
- ↑ Hernandez, KG.; Ezzat, S.; Morel, CF.; Swallow, C.; Otremba, M.; Dickson, BC.; Asa, SL.; Mete, O. (Mar 2015). "Familial pheochromocytoma and renal cell carcinoma syndrome: TMEM127 as a novel candidate gene for the association.". Virchows Arch. doi:10.1007/s00428-015-1755-2. PMID 25800244.
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 Williamson, SR.; Eble, JN.; Amin, MB.; Gupta, NS.; Smith, SC.; Sholl, LM.; Montironi, R.; Hirsch, MS. et al. (Jan 2015). "Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma.". Mod Pathol 28 (1): 80-94. doi:10.1038/modpathol.2014.86. PMID 25034258.
- ↑ 4.0 4.1 4.2 Ricketts, CJ.; Shuch, B.; Vocke, CD.; Metwalli, AR.; Bratslavsky, G.; Middelton, L.; Yang, Y.; Wei, MH. et al. (Dec 2012). "Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer.". J Urol 188 (6): 2063-71. doi:10.1016/j.juro.2012.08.030. PMID 23083876.
External links
- Succinate dehydrogenase-deficient renal carcinoma (cancerdxpathology.org.au) - virtual slides from Gill.